PCDH9 and papillary renal cell carcinoma: LINC00355, also named as lnc-PCDH9-13:1, has been found to abnormally expressed in multiple malignancies such as esophageal squamous cell carcinoma (33), papillary renal cell carcinoma (34), and hepatocellular carcinoma (HCC) (35).